Is Henry Schein (HSIC) overvalued or fairly valued?

MarketChacha shows Henry Schein's valuation in context — a forward P/E of about 14.3, a price-to-book of about 3.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Henry Schein (HSIC)?

Henry Schein last traded at $84.64 (-1.4% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Henry Schein

HSIC · NYSE · Healthcare · United States

$84.64-1.4%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:35 PM

Snapshot

TickerHSIC

ExchangeNYSE

SectorHealthcare

IndustryMedical Distribution

CountryUnited States

CEOMr. Andrea Albertini

Employees25,000

HeadquartersMelville, United States

Market cap$9.6B

P/B3.0

Volume286.17K

Websitewww.henryschein.com

Filings tracked0

About Henry Schein

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.8%
Institutions99.2%
Public & other0.0%

779 institutional holders

As reported by Yahoo Finance.

Top holders

Kohlberg Kravis Roberts & Co. L.P.13.74%
Blackrock Inc.6.17%
Artisan Partners Limited Partnership5.77%
Vanguard Capital Management LLC5.64%
FMR, LLC5.02%
Invesco Ltd.4.29%
JPMORGAN CHASE & CO4.01%
State Street Corporation3.84%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $3.5B · EPS 1.36

Est. earnings growth -1.4%

Next fiscal year

Rev $14.3B · EPS 5.91

Est. earnings growth +10.5%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$61.9552-wk range$89.34

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about HSIC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.